Enhancement of anti-tumor effect of antibody-drug conjugate in combination with nobiletin and other PMFs

被引：0
|
作者：
Masuoka, Tomoya [1 ]
Iwasawa, Takumi [1 ]
Yonezawa, Takayuki [2 ]
Watanabe, Akio [3 ]
Woo, Jetae [2 ]
Kato, Kazunori [1 ]
机构：
[1] Toyo Univ, Grad Sch Sci Eng, Tokyo, Japan
[2] Chubu Univ, Grad Sch Biotech, Kasugai, Aichi, Japan
[3] Jumonji Univ, Niiza, Saitama, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J-1046
引用
收藏
页码：393 / 393
页数：1
相关论文
共 50 条
  • [1] Tumor targeting of a STING agonist with an antibody-drug conjugate elicits potent anti-tumor immune responses
    Cetinbas, Naniye Malli
    Catcott, Kalli
    Avocetien, Kenneth
    Bentley, Keith
    Carter, Tyler
    Chin, Chen-Ni
    Clardy, Susan
    Eitas, Timothy
    Jones, Brian
    Kelleher, Eoin
    Mosher, Rebecca
    Nazzaro, Mark
    Nehilla, Barrett
    Protopopova, Marina
    Shaw, Pamela
    Slocum, Kelly
    Qin, LiuLiang
    Thomas, Josh
    Yang, Liping
    Toader, Dorin
    Damelin, Marc
    Duvall, Jeremy
    Bukhalid, Raghida
    Lowinger, Timothy
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [2] Potent anti-tumor activity of T-DM1 antibody-drug conjugate in combination with chemotherapeutic agents in breast tumor cells
    Parsons, K.
    Fields, C.
    Gunter, B.
    Phillips, G.
    Tibbitts, J.
    EJC SUPPLEMENTS, 2010, 8 (07): : 35 - 35
  • [3] Anti-BCMA antibody-drug conjugate
    Cookson, Emma
    LANCET HAEMATOLOGY, 2021, 8 (01): : E16 - E16
  • [4] Anti-Endosialin Antibody-Drug Conjugate: Potential in Sarcoma and Other Malignancies
    Rouleau, Cecile
    Gianolio, Diego A.
    Smale, Robert
    Roth, Stephanie D.
    Krumbholz, Roy
    Harper, Jay
    Munroe, Kenneth J.
    Green, Tessa L.
    Horten, Bruce C.
    Schmid, Steven M.
    Teicher, Beverly A.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (09) : 2081 - 2089
  • [5] OBI-999, an anti-Globo H antibody drug conjugate, exhibits synergistic anti-tumor effect in combination with pembrolizumab
    Wang, Chun-Chung
    Lu, Chi-Huan
    Yang, Jhih-Jie
    Li, Wan-Fen
    Lai, Ming-Tain
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Anti-tumor effect of antibody-drug conjugate targeting cell adhesion molecule 1 on GIST cells representing small intestinal GIST
    Yoshida, Makoto
    Yuan, Jiayin
    Kihara, Takako
    Kimura, Neinei
    Yamasaki, Takashi
    Ohkouchi, Mizuka
    Hashikura, Yuka
    Isozaki, Koji
    Hagiyama, Man
    Ito, Akihiko
    Hirota, Seiichi
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2024, 139
  • [7] Anti-SSTR2 antibody-drug conjugate for neuroendocrine tumor therapy
    Yingnan Si
    Seulhee Kim
    Jianfa Ou
    Yun Lu
    Patrick Ernst
    Kai Chen
    Jason Whitt
    Angela M. Carter
    James M. Markert
    James A. Bibb
    Herbert Chen
    Lufang Zhou
    Renata Jaskula-Sztul
    Xiaoguang “Margaret” Liu
    Cancer Gene Therapy, 2021, 28 : 799 - 812
  • [8] Anti-SSTR2 antibody-drug conjugate for neuroendocrine tumor therapy
    Si, Yingnan
    Kim, Seulhee
    Ou, Jianfa
    Lu, Yun
    Ernst, Patrick
    Chen, Kai
    Whitt, Jason
    Carter, Angela M.
    Markert, James M.
    Bibb, James A.
    Chen, Herbert
    Zhou, Lufang
    Jaskula-Sztul, Renata
    Liu, Xiaoguang Margaret
    CANCER GENE THERAPY, 2021, 28 (7-8) : 799 - 812
  • [9] Novel Globo H targeting antibody-drug conjugate with binding specificity and anti-tumor efficacy in multiple cancer types
    Yang, Ming-Chen
    Chen, Yu-Jung
    Shia, Chi-Sheng
    Chang, Hui-Wen
    Li, Wan-Fen
    Yu, Cheng-Der Tony
    Chen, I-Ju
    CANCER RESEARCH, 2019, 79 (13)
  • [10] Novel conditionally active biologic anti-Axl antibody-drug conjugate demonstrates anti-tumor efficacy and improved safety profile
    Chang, Cathy
    Frey, Gerhard
    Boyle, William J.
    Sharp, Leslie L.
    Short, Jay M.
    CANCER RESEARCH, 2016, 76
12345